These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 15771796

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma.
    Chen H, Ye D, Xie X, Chen B, Lu W.
    Gynecol Oncol; 2004 Sep; 94(3):630-5. PubMed ID: 15350351
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX, Wu Y, Han HQ, Wang QH.
    Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
    Shi HR, Song WJ, Chen ZM, Wu QH.
    Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response.
    Korpelainen EI, Kärkkäinen M, Gunji Y, Vikkula M, Alitalo K.
    Oncogene; 1999 Jan 07; 18(1):1-8. PubMed ID: 9926914
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma].
    Zhang J, Li YH, Cui AR, Wang JL, Cheng JX, Wang SJ.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec 07; 30(12):905-9. PubMed ID: 19173990
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M.
    Oncol Rep; 2003 Dec 07; 10(1):89-95. PubMed ID: 12469150
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
    Artini PG, Ruggiero M, Monteleone P, Carpi A, Cristello F, Cela V, Genazzani AR.
    Biomed Pharmacother; 2008 Dec 07; 62(6):373-7. PubMed ID: 18037256
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
    Gebhardt M, Mentlein R, Schaudig U, Pufe T, Recker K, Nölle B, Al-Samir K, Geerling G, Paulsen FP.
    Ophthalmology; 2005 Jun 07; 112(6):1023-30. PubMed ID: 15885787
    [Abstract] [Full Text] [Related]

  • 16. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
    Huang Y, Hua K, Zhou X, Jin H, Chen X, Lu X, Yu Y, Zha X, Feng Y.
    Cell Res; 2008 Jul 07; 18(7):780-91. PubMed ID: 18574502
    [Abstract] [Full Text] [Related]

  • 17. [Expression of hSef and FGF-2 in epithelial ovarian tumor].
    Feng QL, Shi HR, Qiao LJ, Zhao J.
    Zhonghua Zhong Liu Za Zhi; 2011 Oct 07; 33(10):770-4. PubMed ID: 22335910
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
    Stadlmann S, Amberger A, Pollheimer J, Gastl G, Offner FA, Margreiter R, Zeimet AG.
    Gynecol Oncol; 2005 Jun 07; 97(3):784-9. PubMed ID: 15943987
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with topoisomerase II alpha and prognosis.
    Brustmann H.
    Gynecol Oncol; 2004 Oct 07; 95(1):16-22. PubMed ID: 15385105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.